| Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study A Fendler, STC Shepherd, L Au, KA Wilkinson, M Wu, F Byrne, M Cerrone, ... Nature cancer 2 (12), 1305-1320, 2021 | 158 | 2021 |
| Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma L Au, E Hatipoglu, MR de Massy, K Litchfield, G Beattie, A Rowan, ... Cancer Cell 39 (11), 1497-1518. e11, 2021 | 152 | 2021 |
| New model for estimating glomerular filtration rate in patients with cancer T Janowitz, EH Williams, A Marshall, N Ainsworth, PB Thomas, ... Journal of Clinical Oncology 35 (24), 2798, 2017 | 99 | 2017 |
| Cytokine release syndrome in a patient with colorectal cancer after vaccination with BNT162b2 L Au, A Fendler, STC Shepherd, K Rzeniewicz, M Cerrone, F Byrne, ... Nature medicine 27 (8), 1362-1366, 2021 | 84 | 2021 |
| Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer A Fendler, STC Shepherd, L Au, M Wu, R Harvey, AM Schmitt, Z Tippu, ... The Lancet 399 (10328), 905-907, 2022 | 74 | 2022 |
| Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer A Fendler, STC Shepherd, L Au, KA Wilkinson, M Wu, AM Schmitt, Z Tippu, ... Cancer Cell 40 (2), 114-116, 2022 | 66 | 2022 |
| Representative sequencing: unbiased sampling of solid tumor tissue K Litchfield, S Stanislaw, L Spain, LL Gallegos, A Rowan, D Schnidrig, ... Cell reports 31 (5), 107550, 2020 | 59 | 2020 |
| Selection of metastasis competent subclones in the tumour interior Y Zhao, X Fu, JI Lopez, A Rowan, L Au, A Fendler, S Hazell, H Xu, ... Nature ecology & evolution 5 (7), 1033-1045, 2021 | 58 | 2021 |
| Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study A Fendler, L Au, STC Shepherd, F Byrne, M Cerrone, LA Boos, ... Nature Cancer 2 (12), 1321-1337, 2021 | 57 | 2021 |
| Treatment and survival outcome of BRAF-mutated metastatic colorectal cancer: a retrospective matched case-control study H Kayhanian, E Goode, F Sclafani, JE Ang, M Gerlinger, DG de Castro, ... Clinical colorectal cancer 17 (1), e69-e76, 2018 | 56 | 2018 |
| Cancer, COVID-19, and antiviral immunity: the CAPTURE study L Au, LA Boos, A Swerdlow, F Byrne, STC Shepherd, A Fendler, S Turajlic Cell 183 (1), 4-10, 2020 | 44 | 2020 |
| Performance of formulae based estimates of glomerular filtration rate for carboplatin dosing in stage 1 seminoma STC Shepherd, G Gillen, P Morrison, C Forte, IR Macpherson, JD White, ... European Journal of Cancer 50 (5), 944-952, 2014 | 36 | 2014 |
| Spatial patterns of tumour growth impact clonal diversification in a computational model and the TRACERx Renal study X Fu, Y Zhao, JI Lopez, A Rowan, L Au, A Fendler, S Hazell, H Xu, ... Nature ecology & evolution 6 (1), 88-102, 2022 | 34 | 2022 |
| Pathological complete response to neoadjuvant systemic therapy in 789 early and locally advanced breast cancer patients: the Royal Marsden experience NML Battisti, V True, N Chaabouni, N Chopra, K Lee, S Shepherd, ... Breast Cancer Research and Treatment 179, 101-111, 2020 | 25 | 2020 |
| Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancer A Fendler, STC Shepherd, L Au, M Wu, R Harvey, KA Wilkinson, ... Cell Reports Medicine 3 (10), 100781, 2022 | 21 | 2022 |
| Rituximab in the treatment of pembrolizumab-induced myasthenia gravis SM Crusz, A Radunovic, S Shepherd, S Shah, V Newey, M Phillips, L Lim, ... European Journal of Cancer 102, 49-51, 2018 | 20 | 2018 |
| Safety and efficacy of T-DM1 in patients with advanced HER2-positive breast cancer The Royal Marsden experience NML Battisti, F Rogerson, K Lee, S Shepherd, K Mohammed, N Turner, ... Cancer Treatment and Research Communications 24, 100188, 2020 | 17 | 2020 |
| Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study. Nat Cancer. 2021 A Fendler, STC Shepherd, L Au, KA Wilkinson, M Wu, F Byrne | 15 | |
| Abemaciclib, a potent cyclin-dependent kinase 4 and 6 inhibitor, for treatment of ER-positive metastatic breast cancer KA Lee, STC Shepherd, SRD Johnston Future Oncology 15 (29), 3309-3326, 2019 | 12 | 2019 |
| A New Mutation in the Promoter Region of the PAX8 Gene Causes True Congenital Hypothyroidism with Thyroid Hypoplasia in a Girl with Down's Syndrome P Hermanns, S Shepherd, M Mansor, J Schulga, J Jones, M Donaldson, ... Thyroid 24 (6), 939-944, 2014 | 12 | 2014 |
